| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.009 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |